Clinical trial
Open access
Sep 2026
Clinical outcomes after reirradiation with dose painting of recurrent or second primary head and neck cancer
Purpose Recurrent or second primary head and neck cancer (rsHNC) presents a radiotherapeutic challenge due to limited tolerance of previously irradiated tissues. These patients could benefit from dose painting (DP), which focuses on delivering maximal dose to areas of high tumor burden while respecting dose constraints...
E. Dale, M. Evensen, C. D. Amdal et al.
· Frontiers in Oncology · 0 citations